Christian Angermayer Net Worth: Estimate, Methodology, Range

As of mid-2026, the most credible public estimate of Christian Angermayer's net worth is approximately $1.2 billion, based on Forbes' real-time figure dated May 23, 2026. That said, this number is an estimate built largely on private-company valuations, and depending on how you weight his various stakes, a defensible range runs from roughly $800 million on the low end to well over $1.5 billion on the high end. Here is what those numbers are based on, where the gaps are, and how to think about them.

Who Christian Angermayer is and why people are asking about his net worth

Christian Angermayer (born April 26, 1978) is a German entrepreneur and investor who built his reputation primarily through Apeiron Investment Group, his private family office and investment firm. Apeiron is the engine behind most of his publicly discussed wealth, with the firm claiming more than $2.5 billion under management as of its most recent leadership bio. He is probably best known internationally as the co-founder and driving force behind atai Life Sciences, a biotech company focused on developing psychedelics-based mental health treatments that went public on Nasdaq in 2021. He has also co-founded blockchain-related ventures including Plasma, and has credits as a film executive producer.

His wealth gets attention for a few intersecting reasons. He operates at the intersection of biotech, crypto, and psychedelics-focused medicine, all sectors that attracted enormous speculative capital in the early 2020s. High-profile co-investors and allies like Peter Thiel have further raised his public profile. And because a meaningful share of his holdings sits in private vehicles, outsiders naturally wonder how much he is actually worth versus how much he manages on behalf of others. Because these types of wealth figures often circulate without full disclosure, readers also ask similar questions about Christian Merck Grey net worth. That distinction matters a lot when interpreting any headline number.

How to estimate Christian Angermayer's net worth the right way

Net worth is straightforward in theory: total assets minus total liabilities. For a billionaire whose wealth is concentrated in private equity stakes and a family office, doing that calculation accurately is genuinely hard. Here is the framework to use.

Assets to account for

• Equity stake in Apeiron Investment Group and any personal co-investment alongside the fund
• Ownership in atai Life Sciences (ATAI), which is publicly traded on Nasdaq and has a disclosed share count, so this piece is actually calculable from public filings
• Positions in private portfolio companies held through Apeiron
• Crypto and blockchain-related holdings (Plasma and others)
• Real estate, personal liquid assets, and any other direct holdings

Liabilities and offsets

The $2.5 billion Apeiron manages is assets under management, not Angermayer's personal net worth. A family office typically invests both the founder's own capital and capital from outside investors. Until Apeiron's ownership structure and LP base are disclosed publicly, you cannot simply attribute that $2.5 billion figure to him personally. Any margin loans, fund leverage, or personal borrowing secured against illiquid assets would also reduce the net figure, but none of that information is public.

What the major estimates actually say

Forbes is the most systematically published source for this figure. Their profile page shows a real-time net worth of $1.2 billion as of May 23, 2026, with a last-updated timestamp of March 10, 2026. That is the anchor number you will see most often cited. If you also want a side-by-side look at Christian w meinecke net worth, compare how those figures are sourced and whether they isolate personal stakes or assets managed through an investment vehicle. Outside of Forbes, there is no comparably rigorous published estimate with a clear methodology for Angermayer specifically. Many aggregator sites repeat the Forbes figure or round it, which is why you often see the same $1.2 billion across multiple pages: they are all drawing from the same upstream source.

The gap between sources is largely a data problem, not a calculation problem. Because most of Angermayer's assets sit in private companies, different analysts will use different valuation multiples, different assumptions about his ownership percentage, and different reference dates for ATAI's share price. If you are also comparing other billionaires, you can use the same approach to look up Christos Mastoras net worth and see how private stakes can change the numbers. That alone can swing an estimate by hundreds of millions of dollars in either direction.

The main wealth drivers behind the number

Understanding where the money actually comes from is more useful than staring at a headline figure. Angermayer's wealth has three primary pillars.

atai Life Sciences (ATAI)

ATAI is the clearest window into Angermayer's wealth because it is a public company. Apeiron was the dominant early backer of ATAI, and Angermayer co-founded the company. SEC filings from the time of its 2021 Nasdaq IPO disclosed significant ownership. However, ATAI's share price has been volatile, swinging dramatically from its IPO highs. At its June 2021 IPO, ATAI opened above $15 per share; it later fell well below $5. That kind of volatility can move the value of a large insider stake by tens or hundreds of millions of dollars in months. Checking the current share price and Angermayer's latest disclosed ownership percentage in ATAI's proxy statement or 13D/13G filings is the most verifiable calculation you can do.

Apeiron Investment Group

Apeiron is Angermayer's family office, described in ATAI's own leadership materials as managing more than $2.5 billion. This is the largest single source of wealth complexity. The firm invests across biotech, technology, and crypto. Because it is private, valuations for its portfolio companies are not publicly disclosed on a regular basis. The key unknown is how much of that $2.5 billion AUM is Angermayer's own capital versus outside investors' capital. Forbes' methodology for billionaires typically attempts to isolate the individual's personal stake, but they do not publish the line-item breakdown for private investors.

Crypto and blockchain ventures

Angermayer co-founded Plasma and has been a vocal crypto advocate and early investor. Crypto holdings are notoriously hard to value because they can be held in wallets that are not disclosed in any public filing. Depending on the timing and size of his positions, these holdings could represent anywhere from a small fraction to a meaningful portion of his net worth.

Salary and earnings vs. net worth: what you can and can't conclude

When people search for net worth, they sometimes mean annual income or salary, but these are very different things. Readers interested in Christophe Minie’s net worth can use a similar approach, comparing public signals with private valuations. Angermayer's primary wealth is equity-based, not salary-based. As a founder and major investor, he does not derive his wealth primarily from a paycheck. Any compensation he draws as an officer or board member of ATAI would appear in the company's proxy statement, but that figure would typically be a small fraction of his equity value.

What you also cannot infer from a net worth figure is his liquid cash position. A $1.2 billion net worth dominated by private equity stakes and a restricted founder position in a public biotech does not mean Angermayer has $1.2 billion to spend tomorrow. Most of that value is illiquid, subject to lock-ups, and dependent on finding a buyer at the assumed valuation. This is a crucial distinction that aggregator sites almost never explain.

Why the number keeps moving

Net worth for someone like Angermayer is not a stable number. Several factors push it up or down constantly.

• ATAI's public share price changes daily, directly adjusting the market value of his disclosed stake
• Private company valuations inside Apeiron's portfolio are marked periodically, not daily, so they lag market reality
• Crypto markets are highly volatile and can move a portfolio by double-digit percentages in weeks
• New investments or exits from portfolio companies change the composition and total value of assets
• Currency effects matter because Angermayer is a European investor with holdings across jurisdictions
• Forbes updates its real-time figures based on its own methodology, and their timestamp does not mean the figure is recalculated at the same frequency as a public stock

This is why the March 2026 Forbes update and the May 2026 real-time figure might both show $1.2 billion but could reflect meaningfully different underlying assumptions. The headline number looks static but the inputs are not.

How to verify the estimate yourself

If you want to audit the $1.2 billion figure or build your own estimate, here is a practical checklist of sources and steps.

1. Go to the SEC's EDGAR database (sec.gov/cgi-bin/browse-edgar) and search for ATAI Life Sciences filings. Pull the most recent proxy statement (DEF 14A) and any Schedule 13D or 13G filings to find Angermayer's current disclosed ownership percentage and share count.
2. Multiply his disclosed share count by the current ATAI share price. This gives you the most verifiable component of his net worth.
3. Check the Forbes billionaires profile directly (not an aggregator) and note both the figure and the 'last updated' date. Forbes publishes methodology notes that explain how they handle private asset valuations.
4. Search for any recent interviews, press releases, or news coverage of Apeiron deals. Major exits or new fundraises can signal valuation changes that have not yet been reflected in a published net worth figure.
5. Look for any UK, Luxembourg, or German corporate filings tied to Apeiron Investment Group. Some jurisdictions require financial disclosures that are not required in the US.
6. Cross-reference any crypto holdings by searching for public statements or wallet disclosures Angermayer may have made in interviews, noting these are almost always self-reported and unverifiable.
7. When you have a figure, stress-test it: apply a 20–30% private-market discount to any non-public holdings (a standard liquidity haircut) and see whether the resulting number is still in the Forbes ballpark. If it is, the estimate is likely consistent.

The honest conclusion from this exercise is that the public record supports the $1.2 billion Forbes estimate as a reasonable base case, but the error bars are wide. A well-documented case can be made for anywhere from $800 million to $1.5 billion depending on the assumptions used. Anyone presenting a single precise figure without showing their work is either working from Forbes or guessing. For a wealth profile of this type, the Forbes figure is the most credible anchor available, and it should be read as a point-in-time estimate rather than a verified balance sheet.

For context, Angermayer occupies a different wealth tier than figures like Christophe de Margerie (whose wealth was tied to a massive publicly traded energy company with fully disclosed financials) but shares the opacity challenge common to private-investment-led fortunes. The more a person's wealth is concentrated in family offices and private biotech, the harder the number is to pin down, and that is exactly the situation here. If you are comparing similar billionaire wealth estimates, you may also want to look at christophe de margerie net worth as a related reference point. Because Christian Angermayer's wealth is handled through private investments and family-office structures, estimates of Christian Yelich's net worth are often vague and inconsistent as well.